Beltsville, MD, United States of America

Sheldon Morris

This inventor holds 1 USPTO granted patent. Top assignee: Albert Einstein College of Medicine. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheldon Morris. Retrieved from https://idiyas.com/inventor/sheldon-morris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sheldon Morris: Innovator in Immunology

Introduction

Sheldon Morris is a notable inventor based in Beltsville, MD (US). He has made significant contributions to the field of immunology, particularly in the treatment of mammals with deficiencies in CD4 and/or CD8 lymphocytes. His innovative approach has the potential to impact medical treatments for various conditions.

Latest Patents

Sheldon Morris holds 1 patent that focuses on methods of treating mammals deficient in CD4 and/or CD8 lymphocytes. The patent describes methods that involve inoculating the mammal with an attenuated mycobacterium. This mycobacterium contains two deletions, which result in attenuated virulence. The patent also discusses the use of these mycobacteria for the manufacture of a medicament aimed at treating mammals with these deficiencies.

Career Highlights

Morris is affiliated with the Albert Einstein College of Medicine, where he continues to advance his research and innovations. His work is crucial in developing new therapeutic strategies for immunological disorders.

Collaborations

Sheldon Morris has collaborated with esteemed colleagues such as William R Jacobs, Jr. and Tsungda Hsu. These partnerships enhance the research and development of innovative treatments in the field of immunology.

Conclusion

Sheldon Morris is a dedicated inventor whose work in immunology is paving the way for new treatment methods. His contributions are vital for advancing medical science and improving health outcomes for affected mammals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…